Correct Answer: B. Aortofemoral bypass
In a 70-year-old female with claudication (thigh pain on walking), the imaging findings (not explicitly stated but implied by the clinical scenario) likely show aortoiliac occlusive disease affecting both the aorta and iliac vessels. Aortofemoral bypass is the gold-standard surgical revascularization for extensive aortoiliac disease, particularly when the disease extends from the infrarenal aorta through both iliac arteries. This bypass graft (typically Dacron) is placed from the infrarenal aorta to both femoral arteries, restoring blood flow to the lower limbs. The procedure is durable, with 5-year patency rates exceeding 85–90% in Indian vascular centers. It is preferred over PTA in this age group because: (1) extensive aortoiliac disease with occlusion (not just stenosis) is poorly suited to endovascular intervention; (2) the patient's age and claudication severity warrant a definitive, long-lasting solution; (3) aortofemoral bypass has superior long-term outcomes compared to PTA alone in occlusive disease. The procedure carries acceptable morbidity in a fit 70-year-old and is the standard of care per Indian vascular surgery guidelines (ASVS recommendations align with international standards).
Why the other options are wrong
A. Iliac Femoroiliac bypass — This is wrong because femoroiliac bypass is used for isolated iliac disease or as a less invasive alternative when the aorta is patent. In aortoiliac occlusive disease affecting the infrarenal aorta and bilateral iliac arteries, femoroiliac bypass does not address the proximal aortic pathology and leaves the diseased aorta untreated, risking inadequate inflow and graft failure. Aortofemoral bypass is superior when aortic involvement is present. C. PTA with stenting — This is wrong because PTA is indicated for stenotic lesions, not occlusions. Aortoiliac occlusive disease (complete blockage) has poor outcomes with endovascular intervention—restenosis rates are high (20–30% at 2 years), and technical success is limited. In a 70-year-old with symptomatic claudication from occlusion, open surgical bypass offers superior durability and is the standard of care. PTA may be considered for short stenotic segments in younger patients or as adjunctive therapy. D. Aorto-iliac bypass — This is wrong because aorto-iliac bypass (aorta to iliac artery) does not extend revascularization to the femoral vessels and lower limbs, leaving the patient with persistent claudication. The goal in symptomatic aortoiliac disease is to restore flow to the femoral arteries and beyond. Aortofemoral bypass (aorta to bilateral femoral arteries) is the anatomically and functionally correct choice to relieve lower-limb ischemia.
High-Yield Facts
- Aortofemoral bypass is the gold standard for extensive aortoiliac occlusive disease with 5-year patency >85% in Indian vascular centers.
- Aortoiliac occlusion (not stenosis) is a contraindication to PTA; open surgical bypass is preferred in symptomatic patients.
- Femoroiliac bypass is reserved for isolated iliac disease or when the aorta is patent; it does not address proximal aortic pathology.
- Age >65 years with claudication from aortoiliac disease warrants surgical revascularization if the patient is a reasonable operative candidate.
- Dacron grafts are standard for aortofemoral bypass; 10-year patency rates approach 70–75% in Indian cohorts.
Mnemonics
AFB Rule for Aortoiliac Disease Aortofemoral Bypass when Aortoiliac disease is extensive. Extends from aorta to Bilateral Femoral arteries. Use when aorta + iliac vessels are involved. PTA Paradox PTA for Stenosis, Surgery for Occlusion. If the vessel is blocked (occluded), endovascular therapy fails; open bypass is needed. If narrowed (stenosis), PTA may work.
NBE Trap
NBE may lure students into choosing PTA by emphasizing the patient's age (70 years) and the less-invasive nature of endovascular therapy. However, the key discriminator is the extent and type of disease (aortoiliac occlusion vs. stenosis); occlusive disease mandates open surgical bypass regardless of age if the patient is fit for surgery.
Clinical Pearl
In Indian vascular practice, a 70-year-old with symptomatic claudication from aortoiliac occlusion who is medically optimized (good cardiac and renal function) is an ideal candidate for aortofemoral bypass. The procedure is well-tolerated, offers durable relief, and prevents progression to critical limb ischemia and amputation—a common endpoint in untreated aortoiliac disease in our population.
_Reference: Bailey & Love Ch. 56 (Arterial Disease); Harrison Ch. 242 (Vascular Disease)_